129 related articles for article (PubMed ID: 8173031)
1. p53 immunostaining as a marker for oral cancer in diagnostic cytopathology--preliminary report.
Ogden GR; Cowpe JG; Chisholm DM; Lane DP
Cytopathology; 1994 Feb; 5(1):47-53. PubMed ID: 8173031
[TBL] [Abstract][Full Text] [Related]
2. Galectin-1 is a useful marker for detecting neoplastic squamous cells in oral cytology smears.
Noda Y; Kondo Y; Sakai M; Sato S; Kishino M
Hum Pathol; 2016 Jun; 52():101-9. PubMed ID: 26980012
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
5. Assessment of p53 protein expression in normal, benign, and malignant oral mucosa.
Ogden GR; Kiddie RA; Lunny DP; Lane DP
J Pathol; 1992 Apr; 166(4):389-94. PubMed ID: 1381431
[TBL] [Abstract][Full Text] [Related]
6. Expression of the tumour suppressor gene p53 in oral cancer.
Langdon JD; Partridge M
Br J Oral Maxillofac Surg; 1992 Aug; 30(4):214-20. PubMed ID: 1380822
[TBL] [Abstract][Full Text] [Related]
7. Valuation of exfoliative cytology as prediction factor in oral mucosa lesions.
Brunotto M; Zárate AM; Cismondi A; Fernández Mdel C; Noher de Halac RI
Med Oral Patol Oral Cir Bucal; 2005 Jul; 10 Suppl 2():E92-102. PubMed ID: 15995578
[TBL] [Abstract][Full Text] [Related]
8. Expression of Ki-67 and p53 in cutaneous free flaps used to reconstruct soft tissue defects following resection of oral squamous cell carcinoma.
Max Robinson C; Prime SS; Paterson IC; Guest PG; Eveson JW
Oral Oncol; 2007 Mar; 43(3):263-71. PubMed ID: 16920383
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of p53 protein in betel- and tobacco-related human oral dysplasia and squamous-cell carcinoma in India.
Kaur J; Srivastava A; Ralhan R
Int J Cancer; 1994 Aug; 58(3):340-5. PubMed ID: 8050814
[TBL] [Abstract][Full Text] [Related]
10. Association of overexpression of p53 oncoprotein with the state of cell proliferation in oral carcinoma.
Warnakulasuriya KA; Johnson NW
J Oral Pathol Med; 1994 Jul; 23(6):246-50. PubMed ID: 7932243
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic significance of chromosome 17 aberrations and P53 gene mutations as prognostic markers in oral squamous cell carcinoma.
Zedan W; Mourad MI; El-Aziz SM; Salamaa NM; Shalaby AA
Diagn Pathol; 2015 Feb; 10():2. PubMed ID: 25881131
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical expression of p53 protein in squamous epithelial carcinomas and normal and dysplastic epithelium of the mouth cavity].
Piffkó J; Bánkfalvi A
Mund Kiefer Gesichtschir; 1997 Mar; 1(2):104-7. PubMed ID: 9410611
[TBL] [Abstract][Full Text] [Related]
13. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Girod SC; Pfeiffer P; Ries J; Pape HD
Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
[TBL] [Abstract][Full Text] [Related]
14. Keratin profiles of normal and malignant oral mucosa using exfoliative cytology.
Ogden GR; McQueen S; Chisholm DM; Lane EB
J Clin Pathol; 1993 Apr; 46(4):352-6. PubMed ID: 7684404
[TBL] [Abstract][Full Text] [Related]
15. [Expression of apoptosis-related protein in epithelial dysplasia and squamous cell carcinoma].
Guan W; Yu S; Gao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Jan; 37(1):65-8. PubMed ID: 11955367
[TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen (PCNA) and p53 in epithelial dysplasia and squamous cell carcinoma of oral mucosa--a marker for poor tumor differentiation, increasing nuclear atypia and invasiveness?
Lan HA; Zain RB; Saitoh M; Muramatsu Y; Shrestha P; Mori M
Anticancer Res; 1996; 16(5B):3059-65. PubMed ID: 8920767
[TBL] [Abstract][Full Text] [Related]
17. Diabetes alters expression of p53 and c-myc in different stages of oral oncogenesis.
Vairaktaris E; Kalokerinos G; Goutzanis L; Spyridonidou S; Vassiliou S; Derka S; Nkenke E; Yapijakis C; Vylliotis A; Lazaris A; Patsouris E
Anticancer Res; 2007; 27(3B):1465-73. PubMed ID: 17595763
[TBL] [Abstract][Full Text] [Related]
18. P53-mutation in smears of oral squamous cell carcinoma.
Friedrich RE; Giese M; Riethdorf S; Loning T
Anticancer Res; 2000; 20(6D):4927-30. PubMed ID: 11326641
[TBL] [Abstract][Full Text] [Related]
19. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotypic analysis of normal mucosa and squamous cell carcinoma of the oral cavity.
Piffkò J; Bànkfalvi A; Joos U; Ofner D; Krassort M; Schmid KW
Cancer Detect Prev; 1999; 23(1):45-56. PubMed ID: 9892990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
